New research reveals that the clinical and demographic characteristics of children and teenagers receiving attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) diagnoses have undergone a significant transformation over the past ten years.
According to a comprehensive study led by the Barcelona Institute for Global Health (ISGlobal)—a research center supported by the "la Caixa" Foundation—in collaboration with Aarhus University, young people diagnosed with ADHD or ASD in Denmark today bear a much closer resemblance to the broader, general population than those who received identical diagnoses a decade ago.
The groundbreaking findings suggest that the well-documented surge in ADHD and ASD diagnoses observed worldwide may partly reflect profound changes in who is being identified, evaluated, and diagnosed by healthcare systems, alongside any potential fluctuations in the underlying biological or environmental likelihood of developing these conditions. The research, which offers a fresh perspective on a heavily debated global trend, was published in the esteemed scientific publication JAMA Psychiatry.
Tracking Changes in ADHD and Autism Diagnoses
For years, epidemiological studies have identified several key demographic, clinical, and socioeconomic characteristics that occur with significantly greater frequency among individuals diagnosed with ADHD or ASD compared to the general population. Historically, these associated factors have included being born prematurely or presenting with a low birth weight, growing up in households with parents possessing lower levels of education or lower overall household income, having a parent with a documented history of psychiatric or mental health disorders, and making considerably greater use of specialized healthcare services well before receiving an official neurodevelopmental diagnosis.
Faced with these established patterns, researchers became increasingly curious about whether these traditional risk profiles and associated characteristics had remained stable as ADHD and ASD diagnoses grew progressively more common across modern societies.
To thoroughly investigate this question, the multidisciplinary research team designed a massive population-based study, analyzing comprehensive health and administrative registry information drawn from more than 2.1 million children and adolescents residing in Denmark. Within this vast cohort, the researchers compared more than 71,000 young individuals who had been formally diagnosed with either ADHD or ASD between the years 2012 and 2022 against a control group consisting of more than 713,000 individuals from the same demographic who had never received either diagnosis.
Differences Narrowed Over 10 Years
The analysis revealed that while young people diagnosed with ADHD or ASD were still statistically more likely than their typical peers to present with many of the characteristics historically linked to these conditions, the magnitude of those differences steadily and markedly declined throughout the entire ten-year study period.
Low birth weight serves as a prime, quantifiable example of this sweeping demographic shift. At the very beginning of the study period, children who were born with a low birth weight were found to be 54 percent more likely to later receive an official ADHD or ASD diagnosis compared to children who were born at a normal, healthy weight. However, by the conclusion of the study period in 2022, that stark difference had plummeted dramatically, dropping down to just 17 percent.
Furthermore, the researchers uncovered comparable, steady declines in the statistical associations involving premature birth as well as several established measures of socioeconomic disadvantage. As clinical awareness and diagnostic pathways evolved, the profile of the typical child receiving a neurodevelopmental diagnosis shifted closer to the societal mainstream.
"The key message is not that these risk factors are no longer important," explains Magnus Elias Tarp, a PhD student at Aarhus University and the first author of the study, reflecting on the implications of the data. "What we found is that people diagnosed in recent years resemble the general population more closely than those who received the same diagnoses a decade ago."
A Different Way to Understand Rising Diagnoses
Much of the extensive scientific literature and public discourse surrounding ADHD and ASD has historically focused on trying to understand why diagnosis rates are climbing so rapidly, or attempting to isolate which specific environmental and genetic factors are associated with a greater likelihood of developing these neurodevelopmental conditions. This new study, however, approaches the modern trend from an entirely different direction by asking whether the underlying population receiving these diagnoses has itself fundamentally changed over time.
The research team notes that several interconnected societal and systemic developments could potentially contribute to this ongoing shift. Public and professional awareness of both ADHD and ASD has increased exponentially over the past ten years, driven by destigmatization campaigns and wider media representation. Concurrently, modern healthcare systems, pediatric practices, and educational institutions may be identifying cases far more effectively and at earlier stages. Furthermore, access to specialized diagnostic evaluations has expanded in many regions, while the clinical thresholds—the specific points at which neurodevelopmental characteristics are considered functionally impairing enough to warrant a diagnosis—may have shifted as diagnostic criteria and clinical practices evolved.
While the current study cannot definitively determine the exact weight or precise contribution of each of these individual factors, the findings indicate that surging diagnosis rates should never be automatically interpreted as direct evidence that the underlying biological occurrence or true prevalence of ADHD or ASD has increased by the exact same margin.
"Our findings help us better understand why ADHD and autism diagnoses have increased so markedly in recent years," says Oleguer Plana-Ripoll, a researcher at both ISGlobal and Aarhus University who served as the senior author of the study.
Plana-Ripoll emphasizes that the results should be interpreted with careful nuance. "They do not show that these conditions are being overdiagnosed or that they have become less severe," he notes. "Rather, they indicate that the population receiving these diagnoses has changed over time, and this needs to be taken into account when interpreting current trends. Further research in other countries would be needed to determine whether these findings can be replicated elsewhere."
What the Findings Could Mean
The implications of this research extend far beyond academic curiosity, potentially reshaping how scientists, clinicians, and policymakers view neurodevelopmental health trends. Researchers point out that these results could fundamentally alter how scientists interpret longitudinal changes in the prevalence of ADHD and ASD across different generations.
Additionally, these insights are expected to be critically important for the practical planning and allocation of healthcare resources, educational support systems, and social services tailored for individuals living with these diagnoses. As the demographic makeup of the diagnosed population broadens to look more like the general public, the types of support and intervention strategies required may also need to adapt accordingly.
Moreover, the findings could influence how researchers analyze and interpret reports of improving clinical and social outcomes among people with ADHD or ASD. Some apparent improvements over time may result partly from changes in the underlying characteristics and baseline circumstances of the population now receiving diagnoses, rather than solely from an improvement in the inherent prognosis or medical management of the conditions themselves.